Plasma α1,3-Fucosyltransferase Deficiency in Schizophrenia
- 1 June 1999
- journal article
- research article
- Published by S. Karger AG in Experimental and Clinical Immunogenetics
- Vol. 16 (3) , 125-130
- https://doi.org/10.1159/000019104
Abstract
Levels of plasma α1,3-fucosyltransferase (α1,3FT) were assayed in 44 patients with schizophrenia and in 50 healthy controls. Significantly reduced enzyme activities were observed in patients (p < 0.05) and 4 unrelated patients were found, for the first time in Japan, to be deficient in the enzyme activity. Two point mutations in the coding region of the FUT6 gene encoding plasma α1,3FT that were responsible for the inactivation of the enzyme activity were detected in those patients. Genotyping of the Le gene (FUT3) in these patients demonstrated that 2 of them were also FUT3 deficient and were grouped as Lewis– individuals whereas the rest were Lewis+.Keywords
This publication has 5 references indexed in Scilit:
- Plasma sialyltransferase levels in psychiatric disorders as a possible indicator of HPA axis functionBiological Psychiatry, 1997
- Identification of a New Plasma α(1,3)Fucosyltransferase (FUT6) Allele Requires an Extended Genotyping StrategyVox Sanguinis, 1996
- A Missense Mutation in the Gene Results in Total Absence of α3-Fucosylation of Human α1-Acid GlycoproteinJournal of Biological Chemistry, 1996
- Schizophrenia and rheumatoid arthritis: a reviewSchizophrenia Research, 1992
- Serum glycoproteins in schizophreniaCarbohydrate Research, 1980